PL1799231T3 - Zastosowanie cyklodekstryny do leczenia i zapobiegania chorobom zapalnym oskrzeli - Google Patents
Zastosowanie cyklodekstryny do leczenia i zapobiegania chorobom zapalnym oskrzeliInfo
- Publication number
- PL1799231T3 PL1799231T3 PL05801277T PL05801277T PL1799231T3 PL 1799231 T3 PL1799231 T3 PL 1799231T3 PL 05801277 T PL05801277 T PL 05801277T PL 05801277 T PL05801277 T PL 05801277T PL 1799231 T3 PL1799231 T3 PL 1799231T3
- Authority
- PL
- Poland
- Prior art keywords
- prevention
- treatment
- inflammatory diseases
- cyclodextrin
- bronchial inflammatory
- Prior art date
Links
- 229920000858 Cyclodextrin Polymers 0.000 title abstract 2
- 208000027866 inflammatory disease Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title 1
- -1 cyclodextrin compound Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04104957A EP1655034A1 (en) | 2004-10-10 | 2004-10-10 | Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases. |
| EP05801277A EP1799231B1 (en) | 2004-10-10 | 2005-09-30 | Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases |
| PCT/EP2005/054966 WO2006037769A1 (en) | 2004-10-10 | 2005-09-30 | Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1799231T3 true PL1799231T3 (pl) | 2010-07-30 |
Family
ID=34929683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05801277T PL1799231T3 (pl) | 2004-10-10 | 2005-09-30 | Zastosowanie cyklodekstryny do leczenia i zapobiegania chorobom zapalnym oskrzeli |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US7829550B2 (pl) |
| EP (2) | EP1655034A1 (pl) |
| JP (1) | JP4989481B2 (pl) |
| AT (1) | ATE456955T1 (pl) |
| DE (1) | DE602005019247D1 (pl) |
| ES (1) | ES2340511T3 (pl) |
| PL (1) | PL1799231T3 (pl) |
| WO (1) | WO2006037769A1 (pl) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9545424B2 (en) | 2007-06-01 | 2017-01-17 | SolAero Med Inc. | Method of treating pulmonary surfactant dysfunction or respiratory distress syndrome by administering cyclodextrin or a derivative thereof |
| JP2013532734A (ja) * | 2010-08-04 | 2013-08-19 | ユニバーシティ オブ バージニア パテント ファウンデーション | 炎症性疾患を治療するための組成物及び方法 |
| AU2013296170A1 (en) | 2012-08-03 | 2015-03-12 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Cyclodextrin for the treatment of lysosomal storage diseases |
| RU2506080C1 (ru) * | 2012-09-25 | 2014-02-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО НижГМА Минздравсоцразвития России) | Способ лечения и профилактики осложнений в полости рта, вызванных приемом ингаляционных гормональных препаратов у больных бронхиальной астмой |
| EP2900246B1 (en) * | 2012-09-27 | 2020-03-25 | SolAeroMed Inc. | Treatment of pulmonary surfactant dysfunction using cholesterol-sequestering cyclodextrins |
| FR3014694B1 (fr) | 2013-12-13 | 2016-11-11 | Roquette Freres | Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de maladies par augmentation du taux de cholesterol-hdl |
| EP2923702A1 (en) * | 2014-03-28 | 2015-09-30 | Universite De Liege | Composition of cyclodextrin with budesonide derivatives for treatment and prevention of pulmonary inflammatory disease |
| CN106413759B (zh) * | 2014-03-28 | 2022-02-22 | 列日大学 | 用于治疗和预防肺部炎症的包含环糊精和布地奈德衍生物的组合物 |
| WO2016201137A1 (en) * | 2015-06-10 | 2016-12-15 | Vtesse, Inc. | Hydroxypropyl beta-cyclodextrin compositions and methods |
| FR3083234B1 (fr) * | 2018-06-29 | 2020-11-27 | Roquette Freres | Nouvelles hydroxypropyl-beta-cyclodextrines et leurs procedes de preparation |
| SG11202013126QA (en) * | 2018-06-29 | 2021-02-25 | Roquette Freres | NOVEL HYDROXYPROPYL-ß-CYCLODEXTRIN AND PROCESS FOR THE PRODUCTION THEREOF |
| BE1027425B1 (fr) * | 2019-07-01 | 2021-02-08 | Aquilon Pharmaceuticals | Composition inhalable comprenant de la cyclodextrine a utiliser dans le traitement d’inflammations nasales |
| BE1027612B1 (fr) | 2019-09-10 | 2021-05-03 | Aquilon Pharmaceuticals | Microparticules en forme de balle de golf pour une utilisation dans le traitement et la prevention de maladies pulmonaires |
| US11045434B1 (en) | 2020-04-01 | 2021-06-29 | UNION therapeutics A/S | Niclosamide formulations for treating disease |
| MA53516A1 (fr) * | 2020-06-15 | 2022-04-29 | Univ Liege | Cyclodextrine utilisée dans le traitement et la prévention de la bronchoconstriction en phase tardive de l'asthme provoqué par des allergènes. |
| BE1030002B1 (fr) | 2021-12-29 | 2023-09-01 | Aquilon Pharmaceuticals | Compositions inhalables comprenant un complexe de hpbcd et de budesonide ou ciclesonide pour le traitement ou la prevention d'une maladie virale respiratoire |
| WO2023118014A1 (en) | 2021-12-20 | 2023-06-29 | Aquilon Pharmaceuticals | Inhalable compositions comprising a complex of hpbcd and budesonide or ciclesonide for the treatment or prevention of a respiratory viral disease or lipopolysaccharide-induced inflammation, in particular lipopolysaccharide-induced inflammation associated with a respiratory viral disease |
| AU2023220047A1 (en) | 2022-02-18 | 2024-09-19 | Beren Therapeutics P.B.C. | Compositions of hydroxypropyl-beta-cyclodextrin and methods of purifying the same |
| BE1031693B1 (fr) | 2023-06-07 | 2025-01-23 | Aquilon Pharmaceuticals | Compositions sans conservateur comprenant un complexe de corticostéroïde et d'hpbcd pour le traitement ou la prévention d'une maladie inflammatoire par administration nasale |
| BE1031691B1 (fr) | 2023-06-07 | 2025-01-23 | Aquilon Pharmaceuticals | Compositions sans conservateur comprenant un complexe de corticostéroïde et d'hpbcd pour le traitement ou la prévention d'une maladie inflammatoire par administration nasale |
| WO2024251923A1 (en) | 2023-06-07 | 2024-12-12 | Aquilon Pharmaceuticals | Preservative-free compositions comprising a complex of a corticosteroid and hpbcd for the treatment or prevention of an inflammatory disease through nasal administration |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4054736A (en) * | 1970-06-10 | 1977-10-18 | Ono Pharmaceutical Co., Ltd. | Clathrate compounds of prostaglandins or their analogues with cyclodextrin |
| JPS62123132A (ja) * | 1985-11-21 | 1987-06-04 | Michio Nakanishi | 気管支喘息治療用組成物 |
| JPS62292719A (ja) * | 1986-06-12 | 1987-12-19 | Kaken Pharmaceut Co Ltd | 外用澄明水溶性製剤 |
| US5254541A (en) * | 1991-11-15 | 1993-10-19 | Merck Frosst Canada, Inc. | (Quinolin-2-ylmethoxy)indole/cyclodextrin complex |
| US5840713A (en) * | 1995-04-03 | 1998-11-24 | Weisz; Paul B. | Therapy for tissue membrane insufficiency |
| EP0934341A1 (en) * | 1996-10-28 | 1999-08-11 | Farmac Nederland B.V. | Inclusion complexes of beta-2-andrenergics for oral mucosal delivery |
| JP2006008568A (ja) * | 2004-06-24 | 2006-01-12 | Cyclochem:Kk | ＩｇＥ抗体抑制剤および食品 |
-
2004
- 2004-10-10 EP EP04104957A patent/EP1655034A1/en not_active Withdrawn
-
2005
- 2005-09-30 ES ES05801277T patent/ES2340511T3/es not_active Expired - Lifetime
- 2005-09-30 WO PCT/EP2005/054966 patent/WO2006037769A1/en not_active Ceased
- 2005-09-30 EP EP05801277A patent/EP1799231B1/en not_active Expired - Lifetime
- 2005-09-30 DE DE602005019247T patent/DE602005019247D1/de not_active Expired - Lifetime
- 2005-09-30 PL PL05801277T patent/PL1799231T3/pl unknown
- 2005-09-30 US US11/664,999 patent/US7829550B2/en active Active
- 2005-09-30 JP JP2007535148A patent/JP4989481B2/ja not_active Expired - Lifetime
- 2005-09-30 AT AT05801277T patent/ATE456955T1/de active
-
2010
- 2010-07-29 US US12/846,241 patent/US20110028432A1/en not_active Abandoned
-
2012
- 2012-05-23 US US13/478,743 patent/US20120295872A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20110028432A1 (en) | 2011-02-03 |
| EP1799231B1 (en) | 2010-02-03 |
| US7829550B2 (en) | 2010-11-09 |
| ATE456955T1 (de) | 2010-02-15 |
| EP1799231A1 (en) | 2007-06-27 |
| EP1655034A1 (en) | 2006-05-10 |
| US20090012041A1 (en) | 2009-01-08 |
| US20120295872A1 (en) | 2012-11-22 |
| ES2340511T3 (es) | 2010-06-04 |
| WO2006037769A1 (en) | 2006-04-13 |
| JP4989481B2 (ja) | 2012-08-01 |
| DE602005019247D1 (de) | 2010-03-25 |
| JP2008515847A (ja) | 2008-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1799231T3 (pl) | Zastosowanie cyklodekstryny do leczenia i zapobiegania chorobom zapalnym oskrzeli | |
| ZA200703601B (en) | Medicaments for the treatment or prevention of fibriotic diseases | |
| WO2006119329A3 (en) | Compositions and methods for the treatment of neurodegenerative diseases | |
| WO2006120176A3 (en) | Combination of the pde4 inhibitor roflumilast and a tetrahydrobiopterin derivative | |
| IL191772A0 (en) | Compounds for the treatment of inflammatory disorders and microbial diseases | |
| IL191637A0 (en) | Compounds for the treatment of inflammatory disorders and microbial diseases | |
| HUS1500058I1 (hu) | Benzoxazint tartalmazó gyógyszer-kombináció légúti betegségek kezelésére | |
| IL184124A0 (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
| ATE534391T1 (de) | 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen | |
| LTC2805723I2 (lt) | Kladribino režimas, skirtas išsėtinei sklerozei gydyti | |
| WO2005085266A3 (en) | Macrocyclic compounds and methods of making and using the same | |
| ZA200801170B (en) | 3,11B-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation | |
| ZA200800981B (en) | Use of SDF-1 for the treatment and/or prevention of neurological diseases | |
| UA88655C2 (ru) | S-миртазапин для лечения прилива крови | |
| WO2005118610A3 (en) | Macrocyclic compounds and methods of making and using the same | |
| IL182008A (en) | Use of an antithrombotic compound for the manufacture of a medicament for pulmonary delivery for prevention or treatment of thrombosis or related disorders | |
| WO2007054566A3 (en) | Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy | |
| WO2008112701A3 (en) | G-substrate for the treatment and prevention of parkinson's disease | |
| IL190842A0 (en) | Use of sdf-1 for the treatment and/or prevention of neurological diseases | |
| AU2004903986A0 (en) | Compounds for the Treatment of Vascular Diseases | |
| HK1124041A (en) | Compounds for the treatment of inflammatory disorders and microbial diseases | |
| HK1123490A (en) | Compounds for the treatment of inflammatory disorders and microbial diseases | |
| EP1868594A4 (en) | GANGLION BLOCKING AGENT FOR THE TREATMENT OF EPITHELINAL DISEASES |